Véronique Lecault
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Véronique Lecault
Véronique Lecault is recorded as CTO at AbCellera Biologics Inc. (ABCL). The proxy statement of AbCellera Biologics Inc. reports total compensation of $2,315,758 for Véronique Lecault in fiscal 2025, including a base salary of $454,000. Disclosed compensation is on record for 6 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
-
2018-01-01–2024-04-29
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at AbCellera Biologics Inc.
Other people whose current roles at this company are on record from its filings.
- Andrew Booth CFO
- Ester Falconer CTO
- Andrew W. Lo Board Member
- John S. Montalbano Board Member
- Lynn Seely, M.D. Board Member
- Stephen Quake, D.Phil. Board Member
- Stephen R. Quake Board Member
- Victor Sandor Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | AbCellera Biologics Inc. (ABCL) | Chief Technology Officer | $454,000 | $2,315,758 |
| 2024 | AbCellera Biologics Inc. (ABCL) | Chief Technology Officer | $460,000 | $3,424,564 |
| 2023 | AbCellera Biologics Inc. (ABCL) | Chief Technology Officer | $460,000 | $650,587 |
| 2022 | AbCellera Biologics Inc. (ABCL) | Chief Operating Officer | $450,000 | $4,688,188 |
| 2021 | AbCellera Biologics Inc. (ABCL) | Chief Operating Officer | $400,000 | $4,313,387 |
| 2020 | AbCellera Biologics Inc. (ABCL) | Chief Operating Officer | $196,533 | $5,950,539 |
Recent activity
No call appearances or filed executive changes recorded yet.